GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The ...

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but ...

Colon cancer is the most commonly diagnosed cancer and third leading cause of cancer deaths. It is also one of the most preventable types of cancer when it is detected early. Colon cancer screening ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

A family doctor writes about the importance of screening for colorectal cancer. (File photo from iStock / Getty Images Plus) Colorectal cancer is a formidable adversary, ranking as the second-leading ...

Kimmie Ng, MD, MPH, is the director of the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute. “For screening, people are considered to be at average risk if they do not have a ...

Colorectal cancer is the second leading cause of cancer-related deaths in the US, despite a high survival rate when detected ...

A recent UCLA study revealed that fewer than one in four eligible adults aged 45-49 underwent colorectal cancer screening ...

The Global Colon Screening Market is expected to reach US$ 23.51 billion by 2033 from US$ 16.45 billion in 2024, with a CAGR of 4.05% from 2025 to 2033. Major drivers propelling this market's growth ...